Acting on insulin
Tuesday, 11 November, 2008
A PhD student from the Garvan Institute in Sydney has discovered a novel action for insulin, describing a new role in glucose uptake.
Freddy Yip and colleagues from the Garvan’s diabetes and obesity research program have found that a member of the myosin motor protein family, 1c, undergoes increased phosphorylation in response to insulin.
Myo1c is thought to play a role in delivering the glucose transporter GLUT4 to the plasma membrane in fat cells.
For people with type 2 diabetes, the team believes there may be blockages in the signal between insulin and Myo1c, perhaps leading to insulin resistance.
The research is published in the November 5 issue of Cell Metabolism [doi:10.1016/j.cmet.2008.09.011].
Heart valve tissues created from stem cells
The breakthrough should help advance our understanding into how human heart valves develop,...
Breast augmentation procedure uses 3D-printed scaffolds
3D-printed scaffold technology from medtech company BellaSeno has been used in a primary breast...
Victoria detects H5N1 avian influenza strain
It follows disease confirmation in seabirds in WA, SA, NSW and Qld and the national decision that...
